SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Market Cap	2.30B -35.8%
Revenue (ttm)	995.03M +4.1%
Net Income	149.95M +11.1%
EPS	0.99 +10.0%
Shares Out	n/a
PE Ratio	15.33
Forward PE	15.66
Dividend	0.18 (1.20%)
Ex-Dividend Date	Feb 4, 2026

Volume	250
Average Volume	1,018
Open	15.10
Previous Close	15.30
Day's Range	15.10 - 15.20
52-Week Range	13.90 - 30.10
Beta	n/a
RSI	54.14
Earnings Date	Feb 11, 2026

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,716
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In fiscal year 2025, FRA:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.